Related Experiment Video
Updated: Jan 6, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Evolving cystic fibrosis care models in the modulator era
Isaac Martin1, Felix Ratjen1, Patrick Flume2
1Division of Respiratory Medicine, Department of Paediatrics, Translational Medicine Research Program, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Cystic fibrosis (CF) care models are evolving with new therapies and telemedicine. Future models should be individualized and flexible, prioritizing equity and safety, with ongoing research to validate approaches.
Area of Science:
- Pulmonology
- Medical Informatics
Background:
- The COVID-19 pandemic accelerated telemedicine adoption in cystic fibrosis (CF) care.
- New CFTR modulators offer personalized treatment options.
Purpose of the Study:
- To review evolving cystic fibrosis care delivery models.
- To explore the impact of CFTR modulators and telemedicine on CF care.
Main Methods:
- Literature review of recent advancements in CF care.
- Analysis of emerging evidence on CFTR modulator efficacy and safety.
- Examination of telemedicine's role in CF patient management.
Main Results:
- CFTR modulator responses are heterogeneous; some patients still progress.
- Therapy de-escalation shows promise but requires long-term safety data.
- Reduced sputum production complicates microbiological surveillance.
- Risk-stratified, hybrid care models are being developed.
Conclusions:
- Future CF care should be individualized, flexible, equitable, and safe.
- Clinical trials and registry data are crucial for validating new models.
- Conservative implementation with multidisciplinary support and monitoring is recommended currently.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:58Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Pancreatitis II: Collaborative Care
Assessment:
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...